Subsequently, we investigated additional contributors to allergic manifestation that may serve as early serum biomarkers capable of distinguishing between the distinct pathogenic mechanisms underlying IgE- and non-IgE-mediated allergy, or alternatively, to differentiate phenotypic variants of AD. This evidence concerns the gene IGHE and allergic disease.